Pfizer bets on cancer drugs to recover from rapid decline of COVID business
Pfizer is pushing to be more involved in cancer drugs after a turbulent year marked by the rapid decline of its COVID business. During a four-hour investor event last week, Pfizer pushed its initative to “accelerate breakthroughs that help people...